Sat.Jul 15, 2023 - Fri.Jul 21, 2023

article thumbnail

After FDA snub, Daiichi's Vanflyta gains US approval and tees up AML clash with Novartis, Astellas

Fierce Pharma

If at first you don’t succeed, try, try again. That’s the lesson Daiichi Sankyo likely took home Friday after scoring a long-awaited U.S. | Some four years after Daiichi Sankyo's quizartinib scored its initial green light in Japan—and suffered a slap-down from drug regulators stateside—the acute myeloid leukemia medicine has won the FDA’s blessing.

Medicine 246
article thumbnail

CX: How is pharma experienced in the US?

Dominic Tyer

The customer experience provided to HCPs in the US is approaching an inflection point, as unsustainable marketing investment choices face a looming reckoning

Pharma 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year.

article thumbnail

Consumer Choice Is the Key to Solving Our Massive Prescription Drugs Non-Adherence Problem

MedCity News

What we need to overcome adherence challenges is a digitally enabled marketplace of options that can be personalized to the patient and the context of their specific condition, pharmacy preference and ability to pay.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare

Fierce Pharma

Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. | Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. A group of lawmakers is working to change that.

Medicine 246
article thumbnail

A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here

PharmaVoice

Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.

Leads 98

More Trending

article thumbnail

Startup Sues Athenahealth, Alleging Trade Secret Theft & Deceptive Practices

MedCity News

Digital health startup Dorsata filed a lawsuit against EHR provider athenahealth and women’s health company Unified Women’s Healthcare. The startup alleged that athenahealth stole trade secrets, used deceptive business practices and breached its contract — and that Unified aided and abetted these purported practices.

article thumbnail

Sandoz doubles down on biosimilars with $90M Slovenia site where it plans to hire 200

Fierce Pharma

Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. | Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. Its latest move follows a separate $400 million pledge to build a plant in the country.

246
246
article thumbnail

Patient Centricity in the Pharma Supply Chain

Pharmaceutical Commerce

The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.

article thumbnail

Sandoz to build Slovenian biosimilar development facility

European Pharmaceutical Review

To support future growth of its biosimilar pipeline, Sandoz is planning to build a Biosimilar Technical Development Center in Slovenia. The company intends to invest approximately $90 million at its site in Ljubljana, Slovenia, to establish a dedicated Sandoz Biopharma Development Center by 2026. With this financial boost, the Ljubljana site is set to become a key location for biosimilar product development at Sandoz. “The new Biosimilar Development Center in Ljubljana will …[help] Sandoz

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Why the Pandemic Was a Turning Point for Nurses Flexing Union Power

MedCity News

Nurse unions and labor experts agree that the pandemic was a turning point that catalyzed nurses to fight for improved working conditions and overall better treatment from their employers. By negotiating new contracts with their employers, unions are working hard to both uphold patient safety and mitigate the nursing field’s debilitating workforce shortage.

Safety 98
article thumbnail

Fierce Pharma Asia—Eisai's subcutaneous Leqembi study; Astellas' IRA lawsuit; and GSK's Taiwan recall

Fierce Pharma

After a recent study of Eisai's subcutaneous Leqembi formulation, the company is touting its "promising" results. | Eisai showed off "promising" results from a modeling and bioavailability study of its subcutaneous Leqembi formulation. Astellas joined the growing list of drugmakers taking on the Inflation Reduction Act with legal action.

Pharma 246
article thumbnail

US DoD enlists VitriVax to develop one-shot vaccine for melioidosis

Pharmaceutical Technology

B. pseudomallei is resistant to many antibiotics and, without treatment, can be lethal to those infected.

98
article thumbnail

Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Covid is Still With Us. What Does That Mean for Your Brain?

MedCity News

We may not fully understand the link between Covid-19 and Alzheimer’s, but we already have the scientific research and tools to address people’s fears, support their cognitive health journey, and reverse the increase of Alzheimer’s.

article thumbnail

Obesity drug shortage expands to Saxenda as Novo Nordisk warns of limited supply for 2023 and beyond

Fierce Pharma

After Novo Nordisk's popular obesity medicine Wegovy went into short supply, people turned to the company first-generation weight-loss drug, Saxenda, for treatment. | After Novo Nordisk's Wegovy became hard to come by, people turned to the company first-generation weight loss drug, Saxenda, for treatment. Now, the company is struggling to handle demand for that product.

Medicine 246
article thumbnail

Scribe and Sanofi expand genetic therapy development deal

Pharmaceutical Technology

Scribe Therapeutics and Sanofi have expanded partnership to progress the development of in vivo genetic therapies to treat genomic diseases.

98
article thumbnail

QMS market to value nearly $4b by 2030

European Pharmaceutical Review

A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97 billion by 2030.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Coalition Applauds Reintroduction of Obesity Treatment Bill, Urges Passage

MedCity News

The Treat and Reduce Obesity Act would expand Medicare coverage for obesity screenings, treatments and therapies like anti-obesity medications. The Health Equity Coalition for Chronic Disease came out in favor of the bill and asked for swift passage.

Medical 98
article thumbnail

‘The Top Line’: The chemotherapy drug shortage, plus this week’s headlines

Fierce Pharma

In this episode of "The Top Line," we talk with Vimala Raghavendran, the vice president of informatics and product development at U.S.

246
246
article thumbnail

Twist and Cancer Research Horizons sign antibody library platform deal

Pharmaceutical Technology

Twist Bioscience and CRUK innovation arm Cancer Research Horizons have signed an agreement for licensing a library of libraries.

98
article thumbnail

CCC Announces Enhancement to Consortia Processing of Open Access Agreements In Its Innovative RightsLink for Scientific Communications Workflow Solution

Copyright Clearance Center

July 18, 2023 – Danvers, Mass. – CCC , the leading provider of Open Access (OA) workflow solutions, announces an enhancement to the processing of OA Agreements for university library consortia in its innovative scholarly communications workflow solution for the OA community, RightsLink for Scientific Communications (RLSC). Earlier this year, CCC engaged with members of the ESAC Initiative and administrators at university libraries representing nine global consortia across the U.S. and Europe to

Media 98
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Healthcare Spending Burden Is Higher for Medicare Households than Non-Medicare Households

MedCity News

On average, Medicare households spent 15% of their total spending on health-related expenses in 2021, versus 7% for non-Medicare households, according to a new KFF report.

article thumbnail

GSK-funded report on adult vaccination rates ?finds major global declines in recent years

Fierce Pharma

While vaccines for COVID-19 have certainly enjoyed the spotlight in recent years, rates of uptake for other shots have sharply declined. | The GSK-funded report looked at adult vaccination data and found a major slump in vaccine adoption over the last few years, save for COVID vaccines.

246
246
article thumbnail

China grants ruquintinib and sintilimab breakthrough therapy status

Pharmaceutical Technology

Hutchmed has secured breakthrough therapy designation from China’s NMPA for fruquintinib and sintilimab combination to treat EMC.

98
article thumbnail

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Pharma Marketing Network

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. By creating and distributing valuable content, businesses can attract and engage their target audience, position themselves as experts in their field, and build trust with potential customers.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

Survey: 85% of Employees Don’t Use Their Mental Health Benefits

MedCity News

More than half of employees said they don’t have mental health benefits in their benefit package or aren’t sure if they do, according to a new survey. About two-thirds of respondents said they would use a digital mental health benefit if it was offered to them.

98
article thumbnail

Argenx raises $1.1B through global stock placement after Vyvgart's CIDP trial win

Fierce Pharma

Right on the heels of a major study win for its star drug Vyvgart, argenx has raised more than $1 billion in cash to support its operations. | Right on the heels of a major study win for its star drug Vyvgart, argenx has raised more than $1 billion in cash to support its operations.

246
246
article thumbnail

Beyfortus approved for US infants against RSV disease

European Pharmaceutical Review

The first preventive option authorised to protect a broad infant population against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) has been approved by the US Food and Drug Administration (FDA). Monoclonal antibody (mAb) treatment Beyfortus (nirsevimab-alip) has been jointly developed by AstraZeneca and Sanofi. Beyfortus is indicated for newborns and infants up to 24 months, who are healthy at term, or preterm.

article thumbnail

Condé Nast Health Unveiled Several New Offerings at June Upfront

PM360

During the 2023 Condé Nast Health Upfront , a virtual event that was held on June 27, the media company revealed several new offerings for advertisers that meet the needs of growing industry trends around influencer marketing, video, authentic engagement, and culture as the newest health KPI. In terms of influencer marketing, Condé Nast announced Allure’s Creators Network and the SELF Care Squad, which will allow advertisers to tap into influential voices in health and align with these carefully

Media 98
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time